NCT03496805View on ClinicalTrials.gov

Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

February 20, 2025

Study Completion Date

August 17, 2025

Conditions
Recurrent Prostate Cancer
Interventions
DRUG

MGE

The patients will take 4 capsules by mouth BID (twice daily).

OTHER

Placebo

The patients will take 4 capsules by mouth BID (twice daily).

OTHER

ADT

Androgen deprivation therapy (ADT) is to be started within 60 days prior to initiation of MGE.

Trial Locations (2)

27157

Wake Forest Baptist Medical Center, Winston-Salem

28144

WG Hefner VA Medical Center, Salisbury

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03496805 - Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy | Biotech Hunter | Biotech Hunter